Higgins Jack 4
4 · Immunome Inc. · Filed Aug 19, 2024
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Higgins Jack
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-08-15$13.93/sh−3,524$49,072→ 16,000 total - Exercise/Conversion
Common Stock
2024-08-15$1.35/sh+19,524$26,357→ 19,524 total - Gift
Common Stock
2024-08-19−2,471→ 13,529 total - Exercise/Conversion
Stock option (right to buy)
2024-08-15−19,524→ 179,040 totalExercise: $1.35Exp: 2032-06-23→ Common Stock (19,524 underlying)
Footnotes (3)
- [F1]The shares were sold pursuant to sell to cover transactions.
- [F2]The weighted average sale price for the transaction report was $13.925, and the range of prices were between $13.800 and $14.020. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F3]25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.